{"id":910284,"date":"2025-11-14T10:08:08","date_gmt":"2025-11-14T15:08:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/"},"modified":"2025-11-14T10:08:08","modified_gmt":"2025-11-14T15:08:08","slug":"slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/","title":{"rendered":"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – RGRD Law"},"content":{"rendered":"
\n

SAN DIEGO, Nov. 14, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP<\/strong><\/a> is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc. (NASDAQ: SLNO) focused on whether Soleno and certain of its executives made false and\/or misleading statements and\/or failed to disclose material information to investors.<\/p>\n

\n If you have information that could assist in the Soleno investigation or if you are a Soleno investor who suffered a loss and would like to learn more, you can provide your information here:<\/strong>\n <\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/cases-soleno-therapeutics-inc-investigation-slno.html<\/strong>
\n <\/a>\n <\/p>\n

\n You can also contact attorneys <\/strong>
\n
\n J.C. Sanchez<\/strong>
\n <\/a>
\n or <\/strong>
\n
\n Jennifer N. Caringal<\/strong>
\n <\/a>
\n of Robbins Geller by calling 800\/449-4900 or via e-mail at <\/strong>
\n
\n info@rgrdlaw.com<\/strong>
\n <\/a>
\n .<\/strong>\n <\/p>\n

\n THE COMPANY: <\/strong>On March 26, 2025, Soleno announced that the U.S. Food and Drug Administration had approved VYKAT XR (diazoxide choline) extended-release tablets for the treatment of hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome.<\/p>\n

\n THE REVELATION: <\/strong>On November 4, 2025, Soleno revealed during its quarterly earnings call that the discontinuation rate of VYKAT XR related to adverse effects was approximately 8% at the end of the third quarter of fiscal 2025. Soleno\u2019s CEO, Anish Bhatnagar, further admitted during the call that Soleno \u201cdid see a disruption in our [VYKAT XR] launch trajectory in the wake of a short seller report that was released in mid-August, mostly in the form of a lower number of start forms and increase discontinuations for non-serious adverse events.\u201d After this news, the price of Soleno shares fell more than 26%.<\/p>\n

\n ABOUT ROBBINS GELLER<\/strong>: Robbins Geller Rudman & Dowd LLP is one of the world\u2019s leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases \u2013 more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs\u2019 firms in the world, and the Firm\u2019s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever \u2013 $7.2 billion \u2013 in In re Enron Corp. Sec. Litig.<\/em> Please visit the following page for more information:<\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/services-litigation-securities-fraud.html<\/strong>
\n <\/a>\n <\/p>\n

Past results do not guarantee future outcomes. \u00a0
Services may be performed by attorneys in any of our offices.\u00a0<\/p>\n

Contact:
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Robbins Geller Rudman & Dowd LLP\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0J.C. Sanchez, Jennifer N. Caringal
\u00a0 \u00a0 \u00a0 \u00a0 655 W. Broadway, Suite 1900, San Diego, CA 92101\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0800-449-4900\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0info@rgrdlaw.com<\/strong><\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO, Nov. 14, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc. (NASDAQ: SLNO) focused on whether Soleno and certain of its executives made false and\/or misleading statements and\/or failed to disclose material information to investors. If you have information that could assist in the Soleno investigation or if you are a Soleno investor who suffered a loss and would like to learn more, you can provide your information here: https:\/\/www.rgrdlaw.com\/cases-soleno-therapeutics-inc-investigation-slno.html You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800\/449-4900 or via e-mail at info@rgrdlaw.com . THE COMPANY: On March 26, 2025, Soleno … <\/p>\n

Continue reading “SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – RGRD Law”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-910284","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Nov. 14, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc. (NASDAQ: SLNO) focused on whether Soleno and certain of its executives made false and\/or misleading statements and\/or failed to disclose material information to investors. If you have information that could assist in the Soleno investigation or if you are a Soleno investor who suffered a loss and would like to learn more, you can provide your information here: https:\/\/www.rgrdlaw.com\/cases-soleno-therapeutics-inc-investigation-slno.html You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800\/449-4900 or via e-mail at info@rgrdlaw.com . THE COMPANY: On March 26, 2025, Soleno … Continue reading "SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – RGRD Law"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-14T15:08:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTc3MSM3MjY0MjIzIzIxMzY1Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – RGRD Law\",\"datePublished\":\"2025-11-14T15:08:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/\"},\"wordCount\":458,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NTc3MSM3MjY0MjIzIzIxMzY1Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/\",\"name\":\"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NTc3MSM3MjY0MjIzIzIxMzY1Nzk=\",\"datePublished\":\"2025-11-14T15:08:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NTc3MSM3MjY0MjIzIzIxMzY1Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NTc3MSM3MjY0MjIzIzIxMzY1Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – RGRD Law\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/","og_locale":"en_US","og_type":"article","og_title":"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law - Market Newsdesk","og_description":"SAN DIEGO, Nov. 14, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc. (NASDAQ: SLNO) focused on whether Soleno and certain of its executives made false and\/or misleading statements and\/or failed to disclose material information to investors. If you have information that could assist in the Soleno investigation or if you are a Soleno investor who suffered a loss and would like to learn more, you can provide your information here: https:\/\/www.rgrdlaw.com\/cases-soleno-therapeutics-inc-investigation-slno.html You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800\/449-4900 or via e-mail at info@rgrdlaw.com . THE COMPANY: On March 26, 2025, Soleno … Continue reading \"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – RGRD Law\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-14T15:08:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTc3MSM3MjY0MjIzIzIxMzY1Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – RGRD Law","datePublished":"2025-11-14T15:08:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/"},"wordCount":458,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTc3MSM3MjY0MjIzIzIxMzY1Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/","name":"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTc3MSM3MjY0MjIzIzIxMzY1Nzk=","datePublished":"2025-11-14T15:08:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTc3MSM3MjY0MjIzIzIxMzY1Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTc3MSM3MjY0MjIzIzIxMzY1Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/slno-investigation-alert-investigation-launched-into-soleno-therapeutics-inc-attorneys-encourage-investors-and-potential-witnesses-to-contact-law-firm-rgrd-law\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – RGRD Law"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/910284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=910284"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/910284\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=910284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=910284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=910284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}